Detsky AS, McLaughlin JR, Baker JP, et al. What is subjective global assessment of nutritional status?JPEN1987;11:8-13.
4.
Dietz HC, Cutting GR, Pyeritz RE, et al. Marfan syndrome caused by a recurrent de novo missense mutation in the fibrillin gene. Nature1991;25:337-9.
5.
Faubion WC, Wesley JR, Khalidi N., et al. Total parenteral nutrition catheter sepsis. JPEN1986;10:642-5.
6.
Grant JPTeam approach. In: Handbook of total parenteral nutrition , 2nd ed. Philadelphia: WB Saunders Co, 1992:5-14.
7.
Hamaoui E.Assessing the nutrition support team. JPEN1987;11:412-21.
8.
Lee B., Godfrey M., Vitale E., et al. Linkage of Marfan syndrome and a phenotypically related disorder to two different fibrillin genes. Nature1991 ;25:330-4.
9.
Malsen CL, Corson GM, Maddox BK, et al. Partial sequence of a candidate gene for the Marfan syndrome . Nature1991;25:334-337.
10.
McKusick VAThe defect in Marfan syndrome. Nature1991;25:279-81.
11.
Pederson FM , Hamberg O., Hess K., et al. The effect of dietary vitamin K on warfarin induced anticoagulation. J Int Med1991;229:517-20.
12.
Purdum PP, Kirby DFShort bowel syndrome: a review of the role of nutrition support. JPEN1991;15:93-101.
13.
Regenstein M.Nutrition support teams-alive, well, and still growing. NCP1992;7:296-301.
14.
Rowe DW, Shapiro JR, and Harris EDHeritable disorders of connective tissue. In: Winters R, ed. Textbook of internal medicine. Philadelphia: JB Lippincott, 1989 :1013-7.
15.
Shearer MJ, McBurney A., Breckenridge AM, et al. Effect of warfarin on the metabolism of phylloquinone (vitamin K): dose-response relationship in man. Clin Sci Mol Med1977;53:62.
16.
Shetty HGM , Backhouse G., Bentley DP, et al. Effective reversal of warfarin-induced excessive anticoagulation with low dose vitamin K. Thromb Haemost1992 ;67:13-5.
17.
Shuttie JWRecent advances in hepatic vitamin K metabolism and function. Hepatology1987;7:367-76.